MeSH D018193 - complex and mixed neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009370:Neoplasms by histologic type
0 Companies
0 Drugs
Success rate
D018193:
Complex and mixed neoplasms
0 Companies
0 Drugs
Success rate
D000235:Adenolymphoma
0 Companies
0 Drugs
Success rate
D002296:Carcinosarcoma
0 Companies
0 Drugs
Success rate
D008637:Mesenchymoma
0 Companies
0 Drugs
Success rate
D008949:Pleomorphic adenoma
0 Companies
0 Drugs
Success rate
D009208:Myoepithelioma
0 Companies
0 Drugs
Success rate
D009396:Wilms tumor
D013945:Thymoma
0 Companies
0 Drugs
Success rate
D018194:Adenomyoma
0 Companies
0 Drugs
Success rate
D018195:Adenosarcoma
0 Companies
0 Drugs
Success rate
D018196:Adenosquamous carcinoma
0 Companies
0 Drugs
Success rate
D018197:Hepatoblastoma
0 Companies
0 Drugs
Success rate
D018198:Malignant mixed tumor
0 Companies
0 Drugs
Success rate
D018199:Mesodermal mixed tumor
0 Companies
0 Drugs
Success rate
D018200:Mullerian mixed tumor
0 Companies
0 Drugs
Success rate
D018201:Mesoblastic nephroma
0 Companies
0 Drugs
Success rate
D018202:Pulmonary blastoma
0 Companies
0 Drugs
Success rate
D018203:Endometrial stromal sarcoma
0 Companies
0 Drugs
Success rate
D018335:Rhabdoid tumor
0 Companies
0 Drugs
Success rate
D055331:Adenomyoepithelioma
0 Companies
0 Drugs
Success rate
D058617:Composite lymphoma
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use